CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia
DOI 10.1055/s-0033-1341704
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Richter, J Hindricks, LM Hopf, K Kley, S Kralisch, T Ebert, U Lößner, M Blüher, M Stumvoll, M Fasshauer
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objective: Fibroblast growth factor (FGF)-21 was recently introduced as a novel adipokine improving glucose metabolism in vitro and in vivo. In the current study, we investigated circulating FGF-21 in preeclampsia (PE), which represents a serious cardiovascular complication in pregnancy and is, therefore, associated with an increased future metabolic and cardiovascular risk for mother and newborn. Material and metho…
Zitieren
Zitierempfehlung
J Richter, J Hindricks, LM Hopf, K Kley, S Kralisch, T Ebert, U Lößner, M Blüher, M Stumvoll, M Fasshauer (2013) Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0033-1341704
Mit CareLit weiterarbeiten